Liver Enzyme Elevations Associated With Two-Month Rifampicin, Isoniazid, Pyrazinamide, And Ethambutol Anti-Tubercular Therapy In Indonesia

被引:0
|
作者
Hanafi, Waqqas [1 ]
Mulyani, Ully A. [2 ]
Perwitasari, Dyah [3 ]
Atthobari, Jarir [1 ]
机构
[1] Univ Gadjah Mada, Fac Med, Yogyakarta, Indonesia
[2] Minist Hlth Indonesia, Hlth Res & Dev, Jakarta, Indonesia
[3] Univ Ahmad Dahlan, Fac Pharm, Yogyakarta, Indonesia
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
790
引用
收藏
页码:458 / 458
页数:1
相关论文
共 2 条
  • [1] A Case of Delusional Disorder With Abuse of Isoniazid, Rifampicin, Pyrazinamide, and Ethambutol, the First-Line Anti-tuberculosis Therapy Drugs in India
    Sathiyamoorthi, Sathiyanarayanan
    Pentapati, Siva Santosh Kumar
    Vullanki, Sai Sreeja
    Avula, Vijaya Chandra Reddy
    Aravindakshan, Rajeev
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (03)
  • [2] INCIDENCE AND PATHOPHYSIOLOGICAL ASPECT OF LIVER-DAMAGE INDUCED BY ANTI-MYCOBACTERIAL THERAPY WITH ISONIAZID, INHG-NA, RIFAMPICIN AND ETHAMBUTOL
    MUSCH, E
    EICHELBAUM, M
    WANG, JK
    VONSASSEN, W
    KASCHELL, HJ
    DENGLER, HJ
    PRAXIS UND KLINIK DER PNEUMOLOGIE, 1981, 35 : 1062 - 1067